Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Net Income (2017 - 2025)

Historic Net Income for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to -$2.2 million.

  • Catheter Precision's Net Income rose 4689.32% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.2 million, marking a year-over-year decrease of 6448.99%. This contributed to the annual value of -$16.6 million for FY2024, which is 7641.7% up from last year.
  • Per Catheter Precision's latest filing, its Net Income stood at -$2.2 million for Q3 2025, which was up 4689.32% from -$7.4 million recorded in Q2 2025.
  • Catheter Precision's 5-year Net Income high stood at $3.1 million for Q3 2021, and its period low was -$66.4 million during Q1 2023.
  • In the last 5 years, Catheter Precision's Net Income had a median value of -$4.1 million in 2024 and averaged -$7.0 million.
  • Its Net Income has fluctuated over the past 5 years, first soared by 126666.67% in 2021, then plummeted by 149396.23% in 2022.
  • Quarter analysis of 5 years shows Catheter Precision's Net Income stood at $3.1 million in 2021, then crashed by 364.9% to -$8.2 million in 2022, then soared by 91.8% to -$669000.0 in 2023, then plummeted by 741.26% to -$5.6 million in 2024, then skyrocketed by 61.12% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q3 2025, -$7.4 million for Q2 2025, and -$4.0 million during Q1 2025.